Cabaletta Bio
IPOCabaletta Bio, Inc.
Cabaletta Bio was founded in 2017, is headquartered in Philadelphia, PA, United States, lists 51–200 employees, and has 2 recorded funding rounds.
- Headquarters
- Philadelphia, PA
- Employees
- 51–200
- Founded
- 2017
- Business Model
- B2B
- Website
- cabalettabio.com
- Last Round
- Series BJan 2019
- Rounds
- 2
- Type
- Public
Indexed holds 2 funding rounds and 5 investors for this company. The full record is or through the API.
About
Cabaletta Bio is a clinical-stage biotechnology company developing targeted CAAR T cell therapies to cure autoimmune diseases.
Summary
Cabaletta Bio is a Biotech company based in Philadelphia, PA, United States, founded in 2017. It lists 51–200 employees. Its most recent funding was a Series B round in Jan 2019. Investors include Deerfield Management, Adage Capital and Boxer Capital.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Oct 2019
Sign up to see all 3 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cabaletta-bio"><img src="https://indexed.vc/api/badge/company/cabaletta-bio" alt="Cabaletta Bio on Indexed.vc" width="260" height="76" /></a>